Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain

There has been debate in recent years about the relative merits of standard fractionation versus hypofractionated radiation for definitive bladder cancer treatment, and this question has gained relevance during the coronavirus disease 2019 pandemic as patients and providers look for shorter treatment courses to limit exposure to the virus. A recently published study by Choudhury et al in Lancet Oncology comparing standard versus hypofractionated...